Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(33%)

Phase Distribution

Ph phase_3

33%

Ph not_applicable

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 3Large-scale testing

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(1)

Detailed Status

Completed2

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 3

Trials by Phase

Phase 31 (33.3%)

N/A2 (66.7%)

Trials by Status

terminated133%

completed267%

Recent Activity

0 active trials

Showing 3 of 3

completedphase_3

Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis

NCT03183245

terminatednot_applicable

Trial of Fistula Versus Graft in Elderly Patients

NCT03668002

completednot_applicable

Comparison of AVF Versus AVG in Elderly Patients Starting Dialysis

NCT02981706

Clinical Trials (3)

Showing 3 of 3 trials

NCT03183245Phase 3

Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis

Completed

NCT03668002Not Applicable

Trial of Fistula Versus Graft in Elderly Patients

Terminated

NCT02981706Not Applicable

Comparison of AVF Versus AVG in Elderly Patients Starting Dialysis

Completed

All 3 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 3